In the next section, we will explore the interaction between GPCR signaling and leptin sensitivity and highlight the therapeutic potential of combining leptin and GPCR ligands, many of which are gut peptides, neurotransmitters, and neural peptides, for obesity treatment. This evidence concerns the gene GPBAR1 and obesity due to melanocortin 4 receptor deficiency.